Prosaposin Hyperglycosylation: a Novel Tumor Immune Escape Mechanism and Implications for Cancer Immunotherapy
Overview
Overview
Journal
Signal Transduct Target Ther
Specialties
Cell Biology
Pharmacology
Pharmacology
Date
2024 Jul 9
PMID
38982080
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Jhunjhunwala S, Hammer C, Delamarre L
. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021; 21(5):298-312.
DOI: 10.1038/s41568-021-00339-z.
View
2.
Giampazolias E, Schulz O, Lim K, Rogers N, Chakravarty P, Srinivasan N
. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity. Cell. 2021; 184(15):4016-4031.e22.
PMC: 8320529.
DOI: 10.1016/j.cell.2021.05.021.
View
3.
Giles J, Globig A, Kaech S, Wherry E
. CD8 T cells in the cancer-immunity cycle. Immunity. 2023; 56(10):2231-2253.
PMC: 11237652.
DOI: 10.1016/j.immuni.2023.09.005.
View
4.
Sharma P, Zhang X, Ly K, Kim J, Wan Q, Kim J
. Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape. Science. 2024; 383(6679):190-200.
PMC: 11398950.
DOI: 10.1126/science.adg1955.
View